Clinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis
Therapeutic Apheresis and Dialysis · 2023
DOI: 10.1111/1744-9987.14030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2023. Verfasst von Shun Tonomura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Peritoneal Dialysis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
We aimed to determine the correlation between the serum urea‐to‐creatinine ratio and residual kidney function (RKF) in patients undergoing peritoneal dialysis (PD), as well as its predictive value for PD‐related outcomes.
Methods
This study included a cross‐sectional study to assess the correlation between serum urea‐to‐creatinine ratio and RKF in 50 patients on PD and a retrospective cohort study to assess the association between serum urea‐to‐creatinine ratio and PD‐related outcomes in 122 patients who initiated PD.
Results
Serum urea‐to‐creatinine ratios had significant positive correlations with renal Kt/V and creatinine clearance values ( r = 0.60, p < 0.001 and r = 0.61, p < 0.001, respectively). Additionally, serum urea‐to‐creatinine ratio was significantly associated with a lower risk of transfer to hemodialysis or PD/hemodialysis hybrid therapy (hazard ratio: 0.84, 95% confidence interval: 0.75–0.95).
Conclusion
The serum urea‐to‐creatinine ratio can be an indicator of RKF and a prognostic factor in patients undergoing PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan.
- Department of Nephrology, International University of Health and Welfare Narita Hospital, Chiba, Japan.
- Apheresis and Dialysis Center, Keio University School of Medicine, Tokyo, Japan.
ORCID-Profile: Kiyotaka Uchiyama, Takashin Nakayama, Daiki Kojima, Tadashi Yoshida, Naoki Washida
Zitieren
APA
Tonomura, S., Uchiyama, K., Nakayama, T., Mitsuno, R., Kojima, D., Hama, E. Y., Nagasaka, T., Nishimura, E. S., Kusahana, E., Takahashi, R., Yoshimoto, N., Yamaguchi, S., Morimoto, K., Yoshida, T., Hayashi, K., Kanda, T., Washida, N., & Itoh, H. (2023). Clinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14030
Vancouver
Tonomura S, Uchiyama K, Nakayama T, Mitsuno R, Kojima D, Hama EY, et al. Clinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis. Therapeutic Apheresis and Dialysis. 2023. doi:10.1111/1744-9987.14030
BibTeX
@article{Tonomura2023,
author = {Tonomura, Shun and Uchiyama, Kiyotaka and Nakayama, Takashin and Mitsuno, Ryunosuke and Kojima, Daiki and Hama, Eriko Yoshida and Nagasaka, Tomoki and Nishimura, Erina Sugita and Kusahana, Ei and Takahashi, Rina and Yoshimoto, Norifumi and Yamaguchi, Shintaro and Morimoto, Kohkichi and Yoshida, Tadashi and Hayashi, Kaori and Kanda, Takeshi and Washida, Naoki and Itoh, Hiroshi},
title = {Clinical significance of serum urea‐to‐creatinine ratio in patients undergoing peritoneal dialysis},
journal = {Therapeutic Apheresis and Dialysis},
year = {2023},
doi = {10.1111/1744-9987.14030}
}
EUVIMED